{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T10:31:50Z","timestamp":1794393110744,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":50,"publisher":"Humana Press","isbn-type":[{"value":"9781461272151","type":"print"},{"value":"9781461216100","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-1-4612-1610-0_24","type":"book-chapter","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T02:37:40Z","timestamp":1313894260000},"page":"383-394","source":"Crossref","is-referenced-by-count":1,"title":["Mechanisms of Action of Intravenous Immunoglobulin (IVIg) in Immune-Mediated Diseases"],"prefix":"10.1007","author":[{"given":"K. A. Nagendra","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel D.","family":"Kazatchkine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas V.","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"24_CR1","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","volume":"306","author":"J Fehr","year":"1982","unstructured":"Fehr, J., Hofmann, V., and Kappeier, U. (1982) Transient reversal of thrombocy-topenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma-globulin. N. Engl. J. Med. 306, 1254\u20131258.","journal-title":"N. Engl. J. Med."},{"key":"24_CR2","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1056\/NEJM198605083141907","volume":"314","author":"SB Clarkson","year":"1986","unstructured":"Clarkson, S. B., Bussel, J. B., Kimberly, R. P., Valinsky, J. E., Nachman, R. L., and Unkeless, J. C. (1986) Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N. Engl. J. Med. 314, 1236\u20131239.","journal-title":"N. Engl. J. Med."},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0952-7915(93)90053-U","volume":"5","author":"W Fridman","year":"1993","unstructured":"Fridman, W. (1993) Regulation of B-cell activation and antigen presentation by Fc receptors. Curr. Opin. Immunol. 5, 355\u2013360.","journal-title":"Curr. Opin. Immunol."},{"key":"24_CR4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood.V74.1.326.326","volume":"74","author":"M Basta","year":"1989","unstructured":"Basta, M., Langlois, P. F., Marques, M., Frank, M. M., and Fries, L. F. (1989) High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. Blood 74, 326\u2013333.","journal-title":"Blood"},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1172\/JCI114387","volume":"84","author":"M Basta","year":"1989","unstructured":"Basta, M., Kirshbom, P., Frank, M. M., and Fries, L. F. (1989) Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model. J. Clin. Invest. 84, 1974\u20131981.","journal-title":"J. Clin. Invest."},{"key":"24_CR6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1172\/JCI117520","volume":"94","author":"M Basta","year":"1994","unstructured":"Basta, M. and Dalakas, M. C. (1994) High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complements fragments. J. Clin. Inv. 94, 1729\u20131735.","journal-title":"J. Clin. Inv."},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4049\/jimmunol.156.2.749","volume":"156","author":"VD Miletic","year":"1996","unstructured":"Miletic, V. D., Hester, C. G., and Frank, M. M. (1996) Regulation of complement activity by Immunoglobulin. J. Immunol. 156, 749\u2013757.","journal-title":"J. Immunol."},{"key":"24_CR8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood.V78.5.1275.1275","volume":"78","author":"DD Poutsiaka","year":"1991","unstructured":"Poutsiaka, D. D., Clark, B. D., Vannier, E., and Dinarello, C. A. (1991) Production of IL-receptor antagonist and IL-l\u03b2 by peripheral blood mononuclear cells is differentially regulated. Blood 78, 1275\u20131279.","journal-title":"Blood"},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/eji.1830250521","volume":"25","author":"V Ruiz de Souza","year":"1995","unstructured":"Ruiz de Souza, V., Carreno, M. P., Kaveri, S. V., Ledur, A., Sadeghi, H., Cavaillon, J. M., et al. (1995) Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur. J. Immunol. 25, 1267\u20131273.","journal-title":"Eur. J. Immunol."},{"key":"24_CR10","first-page":"497","volume":"72","author":"T Shimozato","year":"1991","unstructured":"Shimozato, T., Iwata, M., Kawada, H., and Tamura, N. (1991) Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3\u2032: 5\u2032-monophosphate levels, resulting in suppression of tumor necrosis factor alpha and interleukin-1 production. Immunology 72, 497\u2013501.","journal-title":"Immunology"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1182\/blood.V84.7.2136.2136","volume":"84","author":"P Aukrust","year":"1994","unstructured":"Aukrust, P., Froland, S. S., Liabakk, N. B., Muller, F., Nordoy, I., Haug, C., et al. (1994) Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 84, 2136\u20132143.","journal-title":"Blood"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0167-5699(90)90068-K","volume":"11","author":"K Bendtzen","year":"1990","unstructured":"Bendtzen, K., Svenson, M., Jonsson, V., and Hippe, E. (1990) Autoantibodies to cytokines \u2014 friends or foes? Immunol. Today 11, 167\u2013169.","journal-title":"Immunol. Today"},{"key":"24_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1365-3083.1990.tb03212.x","volume":"32","author":"M Svenson","year":"1990","unstructured":"Svenson, M., Hansen, M. B., and Bendtzen, K. (1990) Distribution and characterization of autoantibodies to interleukin la in normal human sera. Scand. J. Immunol. 32, 695\u2013701.","journal-title":"Scand. J. Immunol."},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1994.tb00854.x","volume":"139","author":"Y Abe","year":"1994","unstructured":"Abe, Y., Horiuchi, A., Miyake, M., and Kimura, S. (1994) Anti-cytokine nature of human immunoglobulin: one possible mechanism of the clinical effect of intravenous therapy. Immunol. Rev. 139, 5\u201319.","journal-title":"Immunol. Rev."},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0140-6736(84)90701-3","volume":"ii","author":"Y Sultan","year":"1984","unstructured":"Sultan, Y., Kazatchkine, M. D., Maisonneuve, P., and Nydegger, U. E. (1984) Anti-idiotypic suppression of autoantibodies to Factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet ii, 765\u2013768.","journal-title":"Lancet"},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.4049\/jimmunol.143.12.4104","volume":"143","author":"F Rossi","year":"1989","unstructured":"Rossi, F. and Kazatchkine, M. D. (1989) Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J. Immunol. 143, 4104\u20134109.","journal-title":"J. Immunol."},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0165-5728(90)90147-F","volume":"29","author":"PA Doom van","year":"1990","unstructured":"van Doom, P. A., Rossi, F., Brand, A., van Lint, M., Vermeiden, M., and Kazatchkine, M. D. (1990) On the mechanism of high dose intravenous immuno-globulin treatment of patients with chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 29, 57\u201364.","journal-title":"J. Neuroimmunol."},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2249.1991.tb05631.x","volume":"83","author":"F Rossi","year":"1991","unstructured":"Rossi, F., Jayne, D. R. W., Lockwood, C. M., and Kazatchkine, M. D. (1991) Antiidiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin. Exp. Immunol. 83, 298\u2013303.","journal-title":"Clin. Exp. Immunol."},{"key":"24_CR19","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/blood.V74.7.2414.2414","volume":"74","author":"P Berchtold","year":"1989","unstructured":"Berchtold, P., Dale, G. L., Tani, P., and McMillan, R. (1989) Inhibition of auto-antibody binding to platelet glycoprotein IIb\/IIIa by anti-idiotypic antibodies in intravenous immunoglobulins. Blood 74, 2414\u20132417.","journal-title":"Blood"},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/BF00918680","volume":"11","author":"R Liblau","year":"1991","unstructured":"Liblau, R., Gajdos, P., Bustarret, F. A., Habib, R. E., Bach, J. F., and Morel, E. (1991) Intravenous gammaglobulin in myasthenia gravis: Interaction with anti-acetylcholine receptor autoantibodies. J. Clin. Immunol. 11, 128\u2013131.","journal-title":"J. Clin. Immunol."},{"key":"24_CR21","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/intimm\/6.11.1651","volume":"6","author":"N Ronda","year":"1994","unstructured":"Ronda, N., Haury, M., Nobrega, A., Kaveri., S. V., Coutinho, A., and Kazatchkine, M. D. (1994) Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int. Immunol. 6, 1651\u20131660.","journal-title":"Int. Immunol."},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1006\/jaut.1994.1039","volume":"7","author":"D Caccavo","year":"1994","unstructured":"Caccavo, D., Vaccaro, F., Ferri, G. M., Amoroso, A., and Bonomo, L. (1994) Antiidiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use. J. Autoimmunity 7, 537\u2013548.","journal-title":"J. Autoimmunity"},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0140-6736(92)92486-Y","volume":"340","author":"V Fremeaux-Bacchi","year":"1992","unstructured":"Fremeaux-Bacchi, V., Maillet, F., Berlan, L., and Kazatchkine, M. D. (1992) Neutralizing antibodies against C3Nef in intravenous immunoglobulin. Lancet 340, 63\u201364.","journal-title":"Lancet"},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1600-065X.1994.tb00858.x","volume":"139","author":"MD Kazatchkine","year":"1994","unstructured":"Kazatchkine, M. D., Dietrich, G., Hurez, V., Ronda, N., Bellon, B., Rossi, F., and Kaveri, S. V. (1994) V Region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (IVIg). Immunol. Rev. 139, 79\u2013107.","journal-title":"Immunol. Rev."},{"key":"24_CR25","first-page":"587","volume":"14","author":"F Dekeyser","year":"1996","unstructured":"Dekeyser, F., Kazatchkine, M. D., Rossi, F., Dang, H., and Talal, N. (1996) Pooled human immunoglobulins contain anti-idiotypes with reactivity against the 4B4\/P36 cross-reactive idiotype. Clin. Exp. Rheumatol. 14, 587\u2013591.","journal-title":"Clin. Exp. Rheumatol."},{"key":"24_CR26","first-page":"311","volume":"74","author":"F Rossi","year":"1988","unstructured":"Rossi, F., Sultan, Y., and Kazatchkine, M. D. (1988) Anti-idiotypes against autoantibodies and alloantibodies to Factor VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins. Clin. Exp. Immunol. 74, 311\u2013316.","journal-title":"Clin. Exp. Immunol."},{"key":"24_CR27","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/0140-6736(91)92797-6","volume":"ii","author":"DRW Jayne","year":"1991","unstructured":"Jayne, D. R. W., Davies, M., Fox, C., and Lockwood, C. M. (1991) Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet ii, 1137\u20131139.","journal-title":"Lancet"},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1172\/JCI114483","volume":"85","author":"G Dietrich","year":"1990","unstructured":"Dietrich, G. and Kazatchkine, M. D. (1990) Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyro-globulin autoantibodies. J. Clin. Invest. 85, 620\u2013625.","journal-title":"J. Clin. Invest."},{"key":"24_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/clin.1994.1019","volume":"70","author":"N Ronda","year":"1994","unstructured":"Ronda, N., Haury, M., Nobrega, A., Coutinho, A., and Kazatchkine, M. D. (1994) Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg). Clin. Immunol. Immunopathol. 70, 124\u2013128.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/clin.1993.1189","volume":"69","author":"SV Kaveri","year":"1993","unstructured":"Kaveri, S. V., Wang, H. T., Rowen, D., Kazatchkine, M. D., and Kohler, H. (1993) Monoclonal anti-idiotypic antibodies against human anti-thyroglobulin autoantibodies recognize idiotopes shared by disease-associated and natural anti-thyroglobulin autoantibodies. Clin. Immunol. Immunopathol. 69, 333\u2013340.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"24_CR31","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.4049\/jimmunol.145.12.4207","volume":"145","author":"SV Kaveri","year":"1990","unstructured":"Kaveri, S. V., Kang, C. Y., and Kohler, H. (1990) Natural mouse and human antibodies bind to a peptide derived from a germline variable heavy chain: evidence for evolutionary conserved self-binding locus. J. Immunol. 145, 4207\u20134213.","journal-title":"J. Immunol."},{"key":"24_CR32","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1126\/science.3368787","volume":"240","author":"C-Y Kang","year":"1988","unstructured":"Kang, C.-Y., Brunck, T. K., Kieber-Emmons, T., Blalock., J. E., and Kohler, H. (1988) Inhibition of self-binding antibodies (autobodies) by a Vh-derived peptide. Science 240, 1034\u20131036.","journal-title":"Science"},{"key":"24_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1172\/JCI115328","volume":"88","author":"R Halpern","year":"1991","unstructured":"Halpern, R., Kaveri, S. V., and Kohler, H. (1991) Human anti-phosphorylcholine antibodies share idiotopes and are self-binding. J. Clin. Invest. 88, 476\u2013482.","journal-title":"J. Clin. Invest."},{"key":"24_CR34","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.4049\/jimmunol.145.11.3807","volume":"145","author":"M Adib","year":"1990","unstructured":"Adib, M., Ragimbeau, J., Avrameas, S., and Ternynck, T. (1990) IgG auto-antibody activity in normal mouse serum is controlled by IgM. J. Immunol. 145, 3807\u20133813.","journal-title":"J. Immunol."},{"key":"24_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/eji.1830230402","volume":"23","author":"V Hurez","year":"1993","unstructured":"Hurez, V., Kaveri, S. V., and Kazatchkine, M. D. (1993) Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur. J. Immunol. 23, 783\u2013789.","journal-title":"Eur. J. Immunol."},{"key":"24_CR36","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1182\/blood.V79.11.2946.2946","volume":"79","author":"G Dietrich","year":"1992","unstructured":"Dietrich, G., Algiman, M., Sultan, Y., Nydegger, U. E., and Kazatchkine, M. D. (1992) Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg). Blood 79, 2946\u20132951.","journal-title":"Blood"},{"key":"24_CR37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1172\/JCI116240","volume":"91","author":"S Takei","year":"1993","unstructured":"Takei, S., Arora, Y., and Walker, S. M. (1993) Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin, Invest. 91, 602\u2013607.","journal-title":"J. Clin, Invest."},{"key":"24_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1365-3083.1996.d01-36.x","volume":"43","author":"V Baudet","year":"1996","unstructured":"Baudet, V., Hurez, V., Lapeyre, C., Kaveri, S. V., and Kazatchkine, M. D. (1996) Intravenous immunoglobulin (IVIg) enhances the selective expansion of V\u03b23+ and V\u03b217+ \u03b1\u03b2 T cells induced by superantigen}. Scand. J. Immunol. 43, 277\u2013282.","journal-title":"Scand. J. Immunol."},{"key":"24_CR39","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1073\/pnas.89.8.3325","volume":"89","author":"JJ Marchalonis","year":"1992","unstructured":"Marchalonis, J. J., Kaymaz, H., Dedeoglu, F., Schlutter, S. F., Yocum, D. E., and Edmundson, A. B. (1992) Human autoantibodies reactive with synthetic auto-antigens from T cell receptor \u03b2 chain. Proc. Natl. Acad. Sci. USA 89, 3325\u20133329.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"24_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2249.1993.tb03407.x","volume":"92","author":"T Vassilev","year":"1993","unstructured":"Vassilev, T., Gelin, C., Kaveri, S. V., Zilber, L., Boumsell, L., and Kazatchkine, M. D. (1993) Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Clin. Exp. Immunol. 92, 369\u2013372.","journal-title":"Clin. Exp. Immunol."},{"key":"24_CR41","first-page":"269","volume":"1","author":"V Hurez","year":"1994","unstructured":"Hurez, V., Kaveri, S. V., Mouhoub, A., Dietrich, G., Mani, J. C., Klatzmann, D., and Kazatchkine, D. (1994) Anti-CD4 activity of normal human immunoglobulins G for therapeutic use (Intravenous immunoglobulin, IVIg). Therap. Immunol. 1, 269\u2013278.","journal-title":"Therap. Immunol."},{"key":"24_CR42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1172\/JCI118488","volume":"97","author":"S Kaveri","year":"1996","unstructured":"Kaveri, S., Vassilev, T., Hurez, V., Lengagne, R., Lefranc, C., Cot, S., et al. (1996) Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use (IVIg). J. Clin. Invest. 97, 865\u2013869.","journal-title":"J. Clin. Invest."},{"key":"24_CR43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/IAI.62.1.280-289.1994","volume":"62","author":"JS Schlesinger","year":"1994","unstructured":"Schlesinger, J. S. and Horwitz, M. A. (1994) A role for natural antibody in the pathogenesis of leprosy: antibody in non-immune serum mediates C3 fixation to the mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect. Immunol. 62, 280\u2013289.","journal-title":"Infect. Immunol."},{"key":"24_CR44","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1182\/blood.V85.7.1920.bloodjournal8571920","volume":"85","author":"U Giger","year":"1995","unstructured":"Giger, U., Sticher, B., Naef, R., Burger, R., and Lutz, H. U. (1995) Naturally occuring human anti-band 3 antoantibodies accelerate clearance of erythrocytes in guinea pigs. Blood 85, 1920\u20131926.","journal-title":"Blood"},{"key":"24_CR45","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/eji.1830250207","volume":"25","author":"MB Hansen","year":"1995","unstructured":"Hansen, M. B., Svenson, M., Abbell, K., Yasukawa, K., Diamant, M., and Bendtzen, K. (1995) Influence of interleukin-6 autoantibodies on IL-6 binding to cellular receptors. Eur. J. Immunol. 25, 348\u2013354.","journal-title":"Eur. J. Immunol."},{"key":"24_CR46","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4049\/jimmunol.152.4.1727","volume":"152","author":"B Thornton","year":"1994","unstructured":"Thornton, B., Vetvicka, P. V., and Ross, G. D. (1994) Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152, 1727\u20131737.","journal-title":"J. Immunol."},{"key":"24_CR47","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.2727702","volume":"244","author":"S Paul","year":"1989","unstructured":"Paul, S., Volle, D. J., Beach, C. M., Johnson, D. R., Powell, M. J., and Massey, R. J. (1989) Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244, 1158\u20131162.","journal-title":"Science"},{"key":"24_CR48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.1585181","volume":"256","author":"AM Shuster","year":"1992","unstructured":"Shuster, A. M., Gololobov, G. V., Kvashuk, O. A., Bogomolova, A. E., Smirnov, I., and Gabibov, A. G. (1992) DNA hydrolyzing autoantibodies. Science 256, 665\u2013669.","journal-title":"Science"},{"key":"24_CR49","first-page":"41","volume":"47","author":"S Paul","year":"1994","unstructured":"Paul, S. (1994) Catalytic activity of anti-ground state antibodies, antibody sub-units, and human autoantibodies. Appl. Biochem. Biotechnol. 47, 41\u201343.","journal-title":"Appl. Biochem. Biotechnol."},{"key":"24_CR50","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.4049\/jimmunol.155.5.2695","volume":"155","author":"R Kalaga","year":"1995","unstructured":"Kalaga, R., Li, L., O\u2019Dell, J. R., and Paul, S. (1995) Unexpected presence of poly-reactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol. 155, 2695\u20132702","journal-title":"J. Immunol."}],"container-title":["Autoimmune Reactions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4612-1610-0_24.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T06:01:14Z","timestamp":1712728874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4612-1610-0_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9781461272151","9781461216100"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/978-1-4612-1610-0_24","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4612-1610-0","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[1999]]}}}